BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 18248319)

  • 1. Critical issues in site-specific targeting of solid tumours: the carrier, the tumour barriers and the bioavailable drug.
    Hamad I; Moghimi SM
    Expert Opin Drug Deliv; 2008 Feb; 5(2):205-19. PubMed ID: 18248319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extravasation of polymeric nanomedicines across tumor vasculature.
    Danquah MK; Zhang XA; Mahato RI
    Adv Drug Deliv Rev; 2011 Jul; 63(8):623-39. PubMed ID: 21144874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.
    Maeda H; Bharate GY; Daruwalla J
    Eur J Pharm Biopharm; 2009 Mar; 71(3):409-19. PubMed ID: 19070661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug penetration in solid tumours.
    Minchinton AI; Tannock IF
    Nat Rev Cancer; 2006 Aug; 6(8):583-92. PubMed ID: 16862189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour-targeted drug and gene delivery: principles and concepts.
    Cassidy J; Schätzlein AG
    Expert Rev Mol Med; 2004 Sep; 6(19):1-17. PubMed ID: 15387893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of anticancer drugs.
    Zee-Cheng RK; Cheng CC
    Methods Find Exp Clin Pharmacol; 1989; 11(7-8):439-529. PubMed ID: 2689812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivering cancer stem cell therapies - a role for nanomedicines?
    Schätzlein AG
    Eur J Cancer; 2006 Jun; 42(9):1309-15. PubMed ID: 16682183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour targeting: biological factors and formulation advances in injectable lipid nanoparticles.
    Shenoy VS; Vijay IK; Murthy RS
    J Pharm Pharmacol; 2005 Apr; 57(4):411-22. PubMed ID: 15831200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles.
    Wong HL; Bendayan R; Rauth AM; Li Y; Wu XY
    Adv Drug Deliv Rev; 2007 Jul; 59(6):491-504. PubMed ID: 17532091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive and active drug targeting: drug delivery to tumors as an example.
    Torchilin VP
    Handb Exp Pharmacol; 2010; (197):3-53. PubMed ID: 20217525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active targeting with particulate drug carriers in tumor therapy: fundamentals and recent progress.
    Marcucci F; Lefoulon F
    Drug Discov Today; 2004 Mar; 9(5):219-28. PubMed ID: 14980540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-dimensional chemotherapy simulations demonstrate fundamental transport and tumor response limitations involving nanoparticles.
    Sinek J; Frieboes H; Zheng X; Cristini V
    Biomed Microdevices; 2004 Dec; 6(4):297-309. PubMed ID: 15548877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymeric anticancer drugs with pH-controlled activation.
    Ulbrich K; Subr V
    Adv Drug Deliv Rev; 2004 Apr; 56(7):1023-50. PubMed ID: 15066758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Targeting of anti-cancer drugs with nano-sized carrier system].
    Yokoyama M; Okano T
    Nihon Rinsho; 1998 Dec; 56(12):3227-34. PubMed ID: 9883646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug delivery to tumours: recent strategies.
    Reddy LH
    J Pharm Pharmacol; 2005 Oct; 57(10):1231-42. PubMed ID: 16259751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand-based targeted therapy for cancer tissue.
    Das M; Mohanty C; Sahoo SK
    Expert Opin Drug Deliv; 2009 Mar; 6(3):285-304. PubMed ID: 19327045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing the pathophysiology of solid tumours: the potential of TNF and other vasoactive agents.
    ten Hagen TL; Eggermont AM
    Int J Hyperthermia; 2006 May; 22(3):241-6. PubMed ID: 16754345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of high molecular weight agents.
    Cassidy J; Newell DR; Wedge SR; Cummings J
    Cancer Surv; 1993; 17():315-41. PubMed ID: 8137346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of polymeric nanoparticles in the targeting drugs carriers].
    Li S; Liu X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):495-7. PubMed ID: 15250165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical pharmacology: proteins for the transport of drugs].
    Drewe J; Krähenbühl S
    Schweiz Med Wochenschr; 2000 May; 130(20):727-31. PubMed ID: 10920849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.